The change in the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR-16) score at 6 weeks was the primary endpoint and was −8 versus −6 in the psilocybin and escitalopram groups, respectively, but this difference did not reach statistical significance.
← all excerpts
The Potential Role of Serotonergic Hallucinogens in Depression Treatment.
2
—
—
The sentences
There was a significant reduction in depression symptoms immediately post-session, which was sustained and approached significance at a 7-day follow-up.